MEYERS JAMES R 1387521 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Meyers James R | DIRECTOR | acq | 13900.0 | 28.02 | 0.81 | 0.0 | Direct | Common Stock | SANGAMO THERAPEUTICS, INC | code A | 49600.0 | 171.83 (SGMO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | 2023-05-24 | 2023-05-24 | 4 | Meyers James R | DIRECTOR | acq | 55000.0 | 100.0 | 3.31 | 2.56 | Direct | Stock Option (Right To Buy) | ARBUTUS BIOPHARMA CORP | code A | 55000.0 | 166.13 (ABUS) |
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Meyers James R | DIRECTOR | acq | 27750.0 | 100.0 | 1.62 | 1.11 | Direct | Stock Option (Right To Buy) | SANGAMO THERAPEUTICS, INC | code A | 27750.0 | 171.83 (SGMO) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Meyers James R | DIRECTOR | acq | 25000.0 | 100.0 | 3.77 | 1.57 | Direct | Stock Option (Right To Buy) | CYTOMX THERAPEUTICS, INC. | code A | 25000.0 | 66.34 (CTMX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)